Inclusion Criteria : 
  -  Women with chronic anovulation or oligomenorrhea defined as spontaneous intermenstrual periods of greater than or equal to 45 days or a total of less than or equal to 8 menses per year . 
  -  Women with Hyperandrogenism defined as a total testosterone greater than 50 ng / dL or a free androgen index greater than 10. 
  -  Women with Polycystic Ovaries on Ultrasound defined as either 12 or more follicles measuring 2 - 9 mm in diameter or increased ovarian volume greater than 10 cm . 
Exclusion Criteria : 
  -  Women with Hyperprolactinemia defined as 2 prolactin levels at least one week apart greater than 30 ng / mL . 
  -  Women with known 21 - hydroxylase deficiency or other enzyme deficiency leading to the congenital adrenal hyperplasia . 
  -  Women with elevated FSH levels greater than 10 mIU / mL . 
  -  Women with uncorrected thyroid disease as per ASRM guidelines for nonpregnant subjects ( TSH less than 0.45 mIU / mL or greater than 4.5 MIU / mL )  . 
  -  Women with a suspected adrenal or ovarian tumor secreting androgens
  -  Women with Cushing's syndrome
  -  Women on confounding medications which affect ovarian function including metformin , hormonal contraceptives or other medications for type 2 diabetes
  -  Women with medical conditions that are contraindications to OTC inositol or previous allergic reactions to the supplement or to the placebo maltodextrin or inulin.